Creganna showcases Micromuscle Technology at MD&M West 2009
GALWAY, Ireland & ANAHEIM, Calif.--(BUSINESS WIRE)--Creganna today announced that it has acquired the technology and patents of Micromuscle AB, Linköping, Sweden. Micromuscle is an advanced, biocompatible electroactive polymer that exhibits physical functionality similar to a human muscle and can be incorporated into medical devices. The technology enables both controlled movement of a device and the active controlled release of substances from a device.
The technology, patents, brand and trademarks of Micromuscle AB were acquired by Creganna after the withdrawal of a significant Venture Capitalist forced the Swedish company to seek voluntary liquidation. Creganna has retained technical personnel of Micromuscle to conduct a technology transfer and is engaged with former customers of Micromuscle to continue development projects incorporating the EAP technology.
“Micromuscle technology is the perfect fit for Creganna and for our customers” said Alan Crean, Director of Business Development at the company. “Creganna have a reputation for excellence in the creation, design and manufacturing of delivery and access devices. Micromuscle technology enables advanced functionality in these types of devices, for example, it demonstrates potential to enhance steerability and deliverability. By offering this technology platform to our customer base we expect it will enable some exciting new design possibilities.”
The controlled movement of Micromuscle EAP is characterized by the ability of the polymer to swell and contract in response to the application of a small electrical stimulus – typically 1-2 Volts. An alternative feature of this characteristic is an electrical stimulus can begin a sequence of substance elution from the polymer.
About Creganna
Creganna create, design and build products and technologies for medical device and lifescience companies. Creganna specialise in the design and manufacturing of delivery devices for minimally and less invasive therapies with particular expertise in catheter and specialty needle solutions. Creganna are trusted suppliers to the world’s largest medical device companies. Creganna’s design and manufacturing facilities are located in the medical device hubs of Galway, Ireland and Marlborough, Massachusetts. More information can be found at www.creganna.com www.micromuscle.com
MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5866667
Contact: Creganna Maura Leahy Cell: +353-86-8552434 Office: + 353-91-735-229 maura.leahy@creganna.com
Source: Creganna
